Skip to content
StockMarketAgent
Direct answer
Salesforce is transitioning from a hyper-growth SaaS pioneer to a mature compounder. The thesis centers on a strategic shift from dilutive M&A to disciplined capital allocation, margin expansion, and robust free cash flow generation. Fair value range: low $172, high $303, with mid-point at $237.
Stock analysis

CRM Salesforce Inc. fair value $237–$303

CRM
By StockMarketAgent.AI team· supervised by
Analysé: 2026-05-09Prochaine mise à jour: 2026-08-09Methodology v2.4Archetype: Mature compounderNYSE · Information Technology
View archive
Cours
$181.82
▲ +55.13 (+30.32%)
Juste valeur
$237
$237–$303
Notation
Achat fort
confidence 88/100
Potentiel de hausse
+30.3%
upside to fair value
Marge de sécurité
$201.41
buy below · 15%
Capitalisation boursière
$148.7B
P/E fwd 12.2
Repli en anglaisFR
Affichage de la source anglaise pendant la traduction
Ce rapport n'a pas encore été traduit. Actualisez dans quelques minutes une fois que la file d'attente de traduction aura rattrapé son retard.

§1 Résumé

  • Transitioning to mature compounder focused on margin expansion and capital return.
  • Exceptional FCF supports aggressive share repurchases.
  • Market over-penalizing top-line fade; under-pricing cash economics.
  • Key risk is a return to undisciplined M&A or high SBC dilution.
Fair value
$237
Margin of safety
+23.3%
Confidence
88/100
Moat
9/10

Educational analysis only — not financial advice. Always do your own due diligence.

$181.82Price
FV $236.95
High $303.18

Salesforce is transitioning from a hyper-growth SaaS pioneer to a mature compounder. The thesis centers on a strategic shift from dilutive M&A to disciplined capital allocation, margin expansion, and robust free cash flow generation.

  • High switching costs within core
    High switching costs within core enterprise ecosystem
  • Deep integration of multi-cloud CRM
    Deep integration of multi-cloud CRM software
  • Cycle upside
    AI-driven product cycles reignite enterprise IT software spending.

§2 Cas baissier

A sustained macroeconomic downturn coupled with deep CRM saturation tests the model. If revenue growthRevenue growthYear-over-year change in revenue, expressed as a percentage. The starting point for any forward-earnings model and the lens through which scale, mix, and pricing power become visible. compresses below 5% and SBCStock-based compensationThe fair-value cost of equity awards (options, RSUs, performance shares) granted to employees. A real economic expense even though it is non-cash. remains elevated, true per-share value erodes despite optical cash generation.

Comment cette thèse peut échouer

Growth Stagnation

20%· Medium

Core software markets saturate entirely, permanently capping top-line growth below 5%.

FV impact
-27%

M&A Relapse

15%· Low

Management abandons disciplined capital allocation, executing large dilutive acquisitions.

FV impact
-35%

AI Displacement

10%· Low

Agentforce fails to gain traction; nimble AI startups displace core service workflows.

FV impact
-20%
Signaux d'alerte précoce à surveiller
MétriqueActuelSeuil de déclenchement
Revenue growth drops below 7% over two consecutive quarters.MonitorDeterioration versus the report thesis
Operating margins stall or compress below 30% target.MonitorDeterioration versus the report thesis
Share repurchases halted in favor of large-scale M&A.MonitorDeterioration versus the report thesis
Agentforce adoption rates disappoint internal targets.MonitorDeterioration versus the report thesis
SBC continues to consume outsized portion of operating cash flow.MonitorDeterioration versus the report thesis

§3 Historique financier

Compte de résultat — six derniers exercices
PosteT−0T−1T−2T−3T−4TCAC
Période2022-01-312023-01-312024-01-312025-01-312026-01-31Trend
Chiffre d'affaires$26.49B$31.35B$34.86B$37.90B$41.53B+11.9%
Marge brute$19.47B$22.99B$26.32B$29.25B$32.26B+13.5%
Résultat d'exploitation$548.0M$1.86B$6.00B$7.67B$8.92B+100.8%
Résultat net$1.44B$208.0M$4.14B$6.20B$7.46B+50.7%
BPA (dilué)$1.48$0.21$4.20$6.36$7.80+51.5%
EBITDA$3.85B$5.64B$9.96B$11.14B$12.55B+34.4%
R&D$4.47B$5.06B$4.91B$5.49B$5.99B+7.6%
SG&A$14.45B$16.08B$14.52B$15.19B$16.35B+3.1%

Scores de qualité

Piotroski F-score
7 / 9
Composite qualité 0–9
Altman Z-score
2.49
Risque de faillite (>3 sûr)
Beneish M-score
-2.66
Risque de manipulation des résultats
OCF / Résultat net
2.01×
>1 indique une qualité élevée des résultats
Seuil de qualité comptable
Pass
Seuil ajusté au secteur
ROIC
9.2%
Rendement du capital investi
§3

Numbers analysis

Allocation du capital

Capital allocation should be evaluated against reinvestment needs, balance-sheet strength, and shareholder returns.

Abonnés individuels — à partir de §411 sections supplémentaires

Lire l'analyse complète — 11 sections supplémentaires.

Competitive moat, industry cycle, peer comparison, intrinsic valuation, sensitivity, scenarios, earnings decision tree, position management, investor perspectives, scorecard, and final recommendation.

Rapport complet pour chaque action couverte
24 mois d'archives de notations
Briefings de liste de suivi + alertes de changement de notation
Export PDF + DOCX dans n'importe quelle langue
Démarrer l'essai gratuit
Annulable à tout moment.
FAQ

CRM — frequently asked questions

  1. Based on our latest analysis, CRM looks meaningfully undervalued. The current price is $182 versus a composite fair-value midpoint of $237 (range $172–$303), which implies roughly 30.3% upside to the midpoint.
Related coverage

Names readers of CRM also follow

Same archetype: mature-compounder
Same sector: Information Technology